Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | STE/STE20/MSN protein kinase | 0.0062 | 0.259 | 0.259 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0162 | 1 | 1 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.0162 | 1 | 1 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0162 | 1 | 1 |
Echinococcus granulosus | serine:threonine protein kinase mig 15 | 0.0086 | 0.4408 | 0.4408 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.0162 | 1 | 1 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.0162 | 1 | 1 |
Echinococcus multilocularis | 0.0062 | 0.259 | 0.259 | |
Echinococcus granulosus | protein kinase | 0.0062 | 0.259 | 0.259 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0162 | 1 | 1 |
Schistosoma mansoni | protein kinase | 0.0087 | 0.4465 | 0.4465 |
Loa Loa (eye worm) | hypothetical protein | 0.0086 | 0.4408 | 0.4408 |
Schistosoma mansoni | protein kinase | 0.0062 | 0.259 | 0.259 |
Brugia malayi | probable protein kinase | 0.0087 | 0.4465 | 0.4465 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.0162 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IZ (functional) | = 6 mm | Antibacterial activity against Escherichia coli assessed as diameter of growth inhibition zone at 50 ug/ml after 24 hr by agar diffusion method | ChEMBL. | No reference |
IZ (functional) | = 8 mm | Antibacterial activity against Escherichia coli assessed as diameter of growth inhibition zone at 100 ug/ml after 24 hr by agar diffusion method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.